ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Heart Failure Treatment Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-31V5777
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Heart Failure Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global Heart Failure Treatment Market Insights, Forecast to 2030

Code: QYRE-Auto-31V5777
Report
December 2024
Pages:119
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Novartis
Merck
Sanofi
Johnson & Johnson
Astrazeneca plc
GlaxoSmithKline PLC
Amgen Inc
Bayer
BMS
Cardiorentis AG
Cytokinetics Inc
Ono Pharmaceuticals
Mylan NV
NCPC
Xinhua Group
Xudong Haipu Pharmaceutical

Heart Failure Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Heart Failure Treatment Market

Heart Failure Treatment Market

The main treatment for heart failure is etiological treatment.Because heart failure is the ultimate state of the heart, the causes of heart failure are different.Some people may have hyperthyroidism induced heart failure, and the treatment plan is to actively correct hyperthyroidism.Some people because arrhythmia causes tachycardia, cardiomyopathy, control arrhythmia, heart failure will improve naturally.There are still some people who have heart failure caused by ischemic heart disease. They need coronary angiography to actively change the state of heart ischemia, and heart failure can be recovered to a certain extent.There are other diseases, so the etiology of heart failure is important.If heart failure occurs, take active medication.Above all, want to use the therapeutics of heart failure normatively, strong heart, diuresis, dilate blood-vessel is a few treatment means to heart failure acute period, can alleviate improve the symptom of the patient.Chronic treatment of heart failure requires the long-term use of ACEI or ARB, beta blockers and diuretic drugs to reduce the length of hospital stay in patients with heart failure and improve their quality of life, as well as three-chamber pacemaker implantation and heart transplantation.
Market Analysis and Insights: Global Heart Failure Treatment Market
The global Heart Failure Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Heart Failure Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Heart Failure Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Heart Failure Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Heart Failure Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Heart Failure Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Heart Failure Treatment revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Heart Failure Treatment Market Report

Report Metric Details
Report Name Heart Failure Treatment Market
CAGR 5%
Segment by Type
  • Drug Treatment
  • Surgical Treatment
Segment by Application
  • Acute Heart Failure
  • Chronic Heart Failure
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Novartis, Merck, Sanofi, Johnson & Johnson, AstraZeneca, GlaxoSmithKline, Amgen, Bayer, BMS, Cardiorentis, Cytokinetics, Ono Pharmaceuticals, Mylan, NCPC, Xinhua Group, Xudong Haipu Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Heart Failure Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Heart Failure Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Heart Failure Treatment revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Heart Failure Treatment Market report?

Ans: The main players in the Heart Failure Treatment Market are Pfizer, Novartis, Merck, Sanofi, Johnson & Johnson, AstraZeneca, GlaxoSmithKline, Amgen, Bayer, BMS, Cardiorentis, Cytokinetics, Ono Pharmaceuticals, Mylan, NCPC, Xinhua Group, Xudong Haipu Pharmaceutical

What are the Application segmentation covered in the Heart Failure Treatment Market report?

Ans: The Applications covered in the Heart Failure Treatment Market report are Acute Heart Failure, Chronic Heart Failure

What are the Type segmentation covered in the Heart Failure Treatment Market report?

Ans: The Types covered in the Heart Failure Treatment Market report are Drug Treatment, Surgical Treatment

Recommended Reports

Cardiac Devices

Heart Disease Drugs

Cardiac Care Therapeutics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Heart Failure Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Drug Treatment
1.2.3 Surgical Treatment
1.3 Market by Application
1.3.1 Global Heart Failure Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Acute Heart Failure
1.3.3 Chronic Heart Failure
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Heart Failure Treatment Market Perspective (2019-2030)
2.2 Global Heart Failure Treatment Growth Trends by Region
2.2.1 Heart Failure Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Heart Failure Treatment Historic Market Size by Region (2019-2024)
2.2.3 Heart Failure Treatment Forecasted Market Size by Region (2025-2030)
2.3 Heart Failure Treatment Market Dynamics
2.3.1 Heart Failure Treatment Industry Trends
2.3.2 Heart Failure Treatment Market Drivers
2.3.3 Heart Failure Treatment Market Challenges
2.3.4 Heart Failure Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Heart Failure Treatment by Players
3.1.1 Global Heart Failure Treatment Revenue by Players (2019-2024)
3.1.2 Global Heart Failure Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Heart Failure Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Heart Failure Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Heart Failure Treatment Market Concentration Ratio
3.4.1 Global Heart Failure Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Heart Failure Treatment Revenue in 2023
3.5 Global Key Players of Heart Failure Treatment Head office and Area Served
3.6 Global Key Players of Heart Failure Treatment, Product and Application
3.7 Global Key Players of Heart Failure Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Heart Failure Treatment Breakdown Data by Type
4.1 Global Heart Failure Treatment Historic Market Size by Type (2019-2024)
4.2 Global Heart Failure Treatment Forecasted Market Size by Type (2025-2030)
5 Heart Failure Treatment Breakdown Data by Application
5.1 Global Heart Failure Treatment Historic Market Size by Application (2019-2024)
5.2 Global Heart Failure Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Heart Failure Treatment Market Size (2019-2030)
6.2 North America Heart Failure Treatment Market Size by Type
6.2.1 North America Heart Failure Treatment Market Size by Type (2019-2024)
6.2.2 North America Heart Failure Treatment Market Size by Type (2025-2030)
6.2.3 North America Heart Failure Treatment Market Share by Type (2019-2030)
6.3 North America Heart Failure Treatment Market Size by Application
6.3.1 North America Heart Failure Treatment Market Size by Application (2019-2024)
6.3.2 North America Heart Failure Treatment Market Size by Application (2025-2030)
6.3.3 North America Heart Failure Treatment Market Share by Application (2019-2030)
6.4 North America Heart Failure Treatment Market Size by Country
6.4.1 North America Heart Failure Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Heart Failure Treatment Market Size by Country (2019-2024)
6.4.3 North America Heart Failure Treatment Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Heart Failure Treatment Market Size (2019-2030)
7.2 Europe Heart Failure Treatment Market Size by Type
7.2.1 Europe Heart Failure Treatment Market Size by Type (2019-2024)
7.2.2 Europe Heart Failure Treatment Market Size by Type (2025-2030)
7.2.3 Europe Heart Failure Treatment Market Share by Type (2019-2030)
7.3 Europe Heart Failure Treatment Market Size by Application
7.3.1 Europe Heart Failure Treatment Market Size by Application (2019-2024)
7.3.2 Europe Heart Failure Treatment Market Size by Application (2025-2030)
7.3.3 Europe Heart Failure Treatment Market Share by Application (2019-2030)
7.4 Europe Heart Failure Treatment Market Size by Country
7.4.1 Europe Heart Failure Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Heart Failure Treatment Market Size by Country (2019-2024)
7.4.3 Europe Heart Failure Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Heart Failure Treatment Market Size (2019-2030)
8.2 China Heart Failure Treatment Market Size by Type
8.2.1 China Heart Failure Treatment Market Size by Type (2019-2024)
8.2.2 China Heart Failure Treatment Market Size by Type (2025-2030)
8.2.3 China Heart Failure Treatment Market Share by Type (2019-2030)
8.3 China Heart Failure Treatment Market Size by Application
8.3.1 China Heart Failure Treatment Market Size by Application (2019-2024)
8.3.2 China Heart Failure Treatment Market Size by Application (2025-2030)
8.3.3 China Heart Failure Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Heart Failure Treatment Market Size (2019-2030)
9.2 Asia Heart Failure Treatment Market Size by Type
9.2.1 Asia Heart Failure Treatment Market Size by Type (2019-2024)
9.2.2 Asia Heart Failure Treatment Market Size by Type (2025-2030)
9.2.3 Asia Heart Failure Treatment Market Share by Type (2019-2030)
9.3 Asia Heart Failure Treatment Market Size by Application
9.3.1 Asia Heart Failure Treatment Market Size by Application (2019-2024)
9.3.2 Asia Heart Failure Treatment Market Size by Application (2025-2030)
9.3.3 Asia Heart Failure Treatment Market Share by Application (2019-2030)
9.4 Asia Heart Failure Treatment Market Size by Region
9.4.1 Asia Heart Failure Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Heart Failure Treatment Market Size by Region (2019-2024)
9.4.3 Asia Heart Failure Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Heart Failure Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Heart Failure Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Heart Failure Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Heart Failure Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Heart Failure Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Heart Failure Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Heart Failure Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Heart Failure Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Heart Failure Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Heart Failure Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Heart Failure Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Heart Failure Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Heart Failure Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Heart Failure Treatment Introduction
11.1.4 Pfizer Revenue in Heart Failure Treatment Business (2019-2024)
11.1.5 Pfizer Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Heart Failure Treatment Introduction
11.2.4 Novartis Revenue in Heart Failure Treatment Business (2019-2024)
11.2.5 Novartis Recent Developments
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Heart Failure Treatment Introduction
11.3.4 Merck Revenue in Heart Failure Treatment Business (2019-2024)
11.3.5 Merck Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Heart Failure Treatment Introduction
11.4.4 Sanofi Revenue in Heart Failure Treatment Business (2019-2024)
11.4.5 Sanofi Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Heart Failure Treatment Introduction
11.5.4 Johnson & Johnson Revenue in Heart Failure Treatment Business (2019-2024)
11.5.5 Johnson & Johnson Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Heart Failure Treatment Introduction
11.6.4 AstraZeneca Revenue in Heart Failure Treatment Business (2019-2024)
11.6.5 AstraZeneca Recent Developments
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Heart Failure Treatment Introduction
11.7.4 GlaxoSmithKline Revenue in Heart Failure Treatment Business (2019-2024)
11.7.5 GlaxoSmithKline Recent Developments
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Amgen Business Overview
11.8.3 Amgen Heart Failure Treatment Introduction
11.8.4 Amgen Revenue in Heart Failure Treatment Business (2019-2024)
11.8.5 Amgen Recent Developments
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Heart Failure Treatment Introduction
11.9.4 Bayer Revenue in Heart Failure Treatment Business (2019-2024)
11.9.5 Bayer Recent Developments
11.10 BMS
11.10.1 BMS Company Details
11.10.2 BMS Business Overview
11.10.3 BMS Heart Failure Treatment Introduction
11.10.4 BMS Revenue in Heart Failure Treatment Business (2019-2024)
11.10.5 BMS Recent Developments
11.11 Cardiorentis
11.11.1 Cardiorentis Company Details
11.11.2 Cardiorentis Business Overview
11.11.3 Cardiorentis Heart Failure Treatment Introduction
11.11.4 Cardiorentis Revenue in Heart Failure Treatment Business (2019-2024)
11.11.5 Cardiorentis Recent Developments
11.12 Cytokinetics
11.12.1 Cytokinetics Company Details
11.12.2 Cytokinetics Business Overview
11.12.3 Cytokinetics Heart Failure Treatment Introduction
11.12.4 Cytokinetics Revenue in Heart Failure Treatment Business (2019-2024)
11.12.5 Cytokinetics Recent Developments
11.13 Ono Pharmaceuticals
11.13.1 Ono Pharmaceuticals Company Details
11.13.2 Ono Pharmaceuticals Business Overview
11.13.3 Ono Pharmaceuticals Heart Failure Treatment Introduction
11.13.4 Ono Pharmaceuticals Revenue in Heart Failure Treatment Business (2019-2024)
11.13.5 Ono Pharmaceuticals Recent Developments
11.14 Mylan
11.14.1 Mylan Company Details
11.14.2 Mylan Business Overview
11.14.3 Mylan Heart Failure Treatment Introduction
11.14.4 Mylan Revenue in Heart Failure Treatment Business (2019-2024)
11.14.5 Mylan Recent Developments
11.15 NCPC
11.15.1 NCPC Company Details
11.15.2 NCPC Business Overview
11.15.3 NCPC Heart Failure Treatment Introduction
11.15.4 NCPC Revenue in Heart Failure Treatment Business (2019-2024)
11.15.5 NCPC Recent Developments
11.16 Xinhua Group
11.16.1 Xinhua Group Company Details
11.16.2 Xinhua Group Business Overview
11.16.3 Xinhua Group Heart Failure Treatment Introduction
11.16.4 Xinhua Group Revenue in Heart Failure Treatment Business (2019-2024)
11.16.5 Xinhua Group Recent Developments
11.17 Xudong Haipu Pharmaceutical
11.17.1 Xudong Haipu Pharmaceutical Company Details
11.17.2 Xudong Haipu Pharmaceutical Business Overview
11.17.3 Xudong Haipu Pharmaceutical Heart Failure Treatment Introduction
11.17.4 Xudong Haipu Pharmaceutical Revenue in Heart Failure Treatment Business (2019-2024)
11.17.5 Xudong Haipu Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Pfizer Inc
Novartis
Merck
Sanofi
Johnson & Johnson
Astrazeneca plc
GlaxoSmithKline PLC
Amgen Inc
Bayer
BMS
Cardiorentis AG
Cytokinetics Inc
Ono Pharmaceuticals
Mylan NV
NCPC
Xinhua Group
Xudong Haipu Pharmaceutical
List of Tables
    Table 1. Global Heart Failure Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Drug Treatment
    Table 3. Key Players of Surgical Treatment
    Table 4. Global Heart Failure Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Heart Failure Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Heart Failure Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Heart Failure Treatment Market Share by Region (2019-2024)
    Table 8. Global Heart Failure Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Heart Failure Treatment Market Share by Region (2025-2030)
    Table 10. Heart Failure Treatment Market Trends
    Table 11. Heart Failure Treatment Market Drivers
    Table 12. Heart Failure Treatment Market Challenges
    Table 13. Heart Failure Treatment Market Restraints
    Table 14. Global Heart Failure Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Heart Failure Treatment Revenue Share by Players (2019-2024)
    Table 16. Global Top Heart Failure Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heart Failure Treatment as of 2023)
    Table 17. Global Heart Failure Treatment Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Heart Failure Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Heart Failure Treatment, Headquarters and Area Served
    Table 20. Global Key Players of Heart Failure Treatment, Product and Application
    Table 21. Global Key Players of Heart Failure Treatment, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Heart Failure Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Heart Failure Treatment Revenue Market Share by Type (2019-2024)
    Table 25. Global Heart Failure Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Heart Failure Treatment Revenue Market Share by Type (2025-2030)
    Table 27. Global Heart Failure Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Heart Failure Treatment Revenue Share by Application (2019-2024)
    Table 29. Global Heart Failure Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Heart Failure Treatment Revenue Share by Application (2025-2030)
    Table 31. North America Heart Failure Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Heart Failure Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Heart Failure Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Heart Failure Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Heart Failure Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Heart Failure Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Heart Failure Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Heart Failure Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Heart Failure Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Heart Failure Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Heart Failure Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Heart Failure Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Heart Failure Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Heart Failure Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Heart Failure Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Heart Failure Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Heart Failure Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Heart Failure Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Heart Failure Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Heart Failure Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Heart Failure Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Heart Failure Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Heart Failure Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Heart Failure Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Heart Failure Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Heart Failure Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Heart Failure Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Heart Failure Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Heart Failure Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Heart Failure Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Heart Failure Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Heart Failure Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Pfizer Company Details
    Table 64. Pfizer Business Overview
    Table 65. Pfizer Heart Failure Treatment Product
    Table 66. Pfizer Revenue in Heart Failure Treatment Business (2019-2024) & (US$ Million)
    Table 67. Pfizer Recent Developments
    Table 68. Novartis Company Details
    Table 69. Novartis Business Overview
    Table 70. Novartis Heart Failure Treatment Product
    Table 71. Novartis Revenue in Heart Failure Treatment Business (2019-2024) & (US$ Million)
    Table 72. Novartis Recent Developments
    Table 73. Merck Company Details
    Table 74. Merck Business Overview
    Table 75. Merck Heart Failure Treatment Product
    Table 76. Merck Revenue in Heart Failure Treatment Business (2019-2024) & (US$ Million)
    Table 77. Merck Recent Developments
    Table 78. Sanofi Company Details
    Table 79. Sanofi Business Overview
    Table 80. Sanofi Heart Failure Treatment Product
    Table 81. Sanofi Revenue in Heart Failure Treatment Business (2019-2024) & (US$ Million)
    Table 82. Sanofi Recent Developments
    Table 83. Johnson & Johnson Company Details
    Table 84. Johnson & Johnson Business Overview
    Table 85. Johnson & Johnson Heart Failure Treatment Product
    Table 86. Johnson & Johnson Revenue in Heart Failure Treatment Business (2019-2024) & (US$ Million)
    Table 87. Johnson & Johnson Recent Developments
    Table 88. AstraZeneca Company Details
    Table 89. AstraZeneca Business Overview
    Table 90. AstraZeneca Heart Failure Treatment Product
    Table 91. AstraZeneca Revenue in Heart Failure Treatment Business (2019-2024) & (US$ Million)
    Table 92. AstraZeneca Recent Developments
    Table 93. GlaxoSmithKline Company Details
    Table 94. GlaxoSmithKline Business Overview
    Table 95. GlaxoSmithKline Heart Failure Treatment Product
    Table 96. GlaxoSmithKline Revenue in Heart Failure Treatment Business (2019-2024) & (US$ Million)
    Table 97. GlaxoSmithKline Recent Developments
    Table 98. Amgen Company Details
    Table 99. Amgen Business Overview
    Table 100. Amgen Heart Failure Treatment Product
    Table 101. Amgen Revenue in Heart Failure Treatment Business (2019-2024) & (US$ Million)
    Table 102. Amgen Recent Developments
    Table 103. Bayer Company Details
    Table 104. Bayer Business Overview
    Table 105. Bayer Heart Failure Treatment Product
    Table 106. Bayer Revenue in Heart Failure Treatment Business (2019-2024) & (US$ Million)
    Table 107. Bayer Recent Developments
    Table 108. BMS Company Details
    Table 109. BMS Business Overview
    Table 110. BMS Heart Failure Treatment Product
    Table 111. BMS Revenue in Heart Failure Treatment Business (2019-2024) & (US$ Million)
    Table 112. BMS Recent Developments
    Table 113. Cardiorentis Company Details
    Table 114. Cardiorentis Business Overview
    Table 115. Cardiorentis Heart Failure Treatment Product
    Table 116. Cardiorentis Revenue in Heart Failure Treatment Business (2019-2024) & (US$ Million)
    Table 117. Cardiorentis Recent Developments
    Table 118. Cytokinetics Company Details
    Table 119. Cytokinetics Business Overview
    Table 120. Cytokinetics Heart Failure Treatment Product
    Table 121. Cytokinetics Revenue in Heart Failure Treatment Business (2019-2024) & (US$ Million)
    Table 122. Cytokinetics Recent Developments
    Table 123. Ono Pharmaceuticals Company Details
    Table 124. Ono Pharmaceuticals Business Overview
    Table 125. Ono Pharmaceuticals Heart Failure Treatment Product
    Table 126. Ono Pharmaceuticals Revenue in Heart Failure Treatment Business (2019-2024) & (US$ Million)
    Table 127. Ono Pharmaceuticals Recent Developments
    Table 128. Mylan Company Details
    Table 129. Mylan Business Overview
    Table 130. Mylan Heart Failure Treatment Product
    Table 131. Mylan Revenue in Heart Failure Treatment Business (2019-2024) & (US$ Million)
    Table 132. Mylan Recent Developments
    Table 133. NCPC Company Details
    Table 134. NCPC Business Overview
    Table 135. NCPC Heart Failure Treatment Product
    Table 136. NCPC Revenue in Heart Failure Treatment Business (2019-2024) & (US$ Million)
    Table 137. NCPC Recent Developments
    Table 138. Xinhua Group Company Details
    Table 139. Xinhua Group Business Overview
    Table 140. Xinhua Group Heart Failure Treatment Product
    Table 141. Xinhua Group Revenue in Heart Failure Treatment Business (2019-2024) & (US$ Million)
    Table 142. Xinhua Group Recent Developments
    Table 143. Xudong Haipu Pharmaceutical Company Details
    Table 144. Xudong Haipu Pharmaceutical Business Overview
    Table 145. Xudong Haipu Pharmaceutical Heart Failure Treatment Product
    Table 146. Xudong Haipu Pharmaceutical Revenue in Heart Failure Treatment Business (2019-2024) & (US$ Million)
    Table 147. Xudong Haipu Pharmaceutical Recent Developments
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Heart Failure Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Heart Failure Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Drug Treatment Features
    Figure 4. Surgical Treatment Features
    Figure 5. Global Heart Failure Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Heart Failure Treatment Market Share by Application: 2023 VS 2030
    Figure 7. Acute Heart Failure Case Studies
    Figure 8. Chronic Heart Failure Case Studies
    Figure 9. Heart Failure Treatment Report Years Considered
    Figure 10. Global Heart Failure Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 11. Global Heart Failure Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Heart Failure Treatment Market Share by Region: 2023 VS 2030
    Figure 13. Global Heart Failure Treatment Market Share by Players in 2023
    Figure 14. Global Top Heart Failure Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heart Failure Treatment as of 2023)
    Figure 15. The Top 10 and 5 Players Market Share by Heart Failure Treatment Revenue in 2023
    Figure 16. North America Heart Failure Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 17. North America Heart Failure Treatment Market Share by Type (2019-2030)
    Figure 18. North America Heart Failure Treatment Market Share by Application (2019-2030)
    Figure 19. North America Heart Failure Treatment Market Share by Country (2019-2030)
    Figure 20. United States Heart Failure Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada Heart Failure Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Heart Failure Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 23. Europe Heart Failure Treatment Market Share by Type (2019-2030)
    Figure 24. Europe Heart Failure Treatment Market Share by Application (2019-2030)
    Figure 25. Europe Heart Failure Treatment Market Share by Country (2019-2030)
    Figure 26. Germany Heart Failure Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France Heart Failure Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. Heart Failure Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy Heart Failure Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia Heart Failure Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries Heart Failure Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. China Heart Failure Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 33. China Heart Failure Treatment Market Share by Type (2019-2030)
    Figure 34. China Heart Failure Treatment Market Share by Application (2019-2030)
    Figure 35. Asia Heart Failure Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. Asia Heart Failure Treatment Market Share by Type (2019-2030)
    Figure 37. Asia Heart Failure Treatment Market Share by Application (2019-2030)
    Figure 38. Asia Heart Failure Treatment Market Share by Region (2019-2030)
    Figure 39. Japan Heart Failure Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. South Korea Heart Failure Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. China Taiwan Heart Failure Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Southeast Asia Heart Failure Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. India Heart Failure Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Australia Heart Failure Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East, Africa, and Latin America Heart Failure Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Heart Failure Treatment Market Share by Type (2019-2030)
    Figure 47. Middle East, Africa, and Latin America Heart Failure Treatment Market Share by Application (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Heart Failure Treatment Market Share by Country (2019-2030)
    Figure 49. Brazil Heart Failure Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Mexico Heart Failure Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Turkey Heart Failure Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Heart Failure Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Israel Heart Failure Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. GCC Countries Heart Failure Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Pfizer Revenue Growth Rate in Heart Failure Treatment Business (2019-2024)
    Figure 56. Novartis Revenue Growth Rate in Heart Failure Treatment Business (2019-2024)
    Figure 57. Merck Revenue Growth Rate in Heart Failure Treatment Business (2019-2024)
    Figure 58. Sanofi Revenue Growth Rate in Heart Failure Treatment Business (2019-2024)
    Figure 59. Johnson & Johnson Revenue Growth Rate in Heart Failure Treatment Business (2019-2024)
    Figure 60. AstraZeneca Revenue Growth Rate in Heart Failure Treatment Business (2019-2024)
    Figure 61. GlaxoSmithKline Revenue Growth Rate in Heart Failure Treatment Business (2019-2024)
    Figure 62. Amgen Revenue Growth Rate in Heart Failure Treatment Business (2019-2024)
    Figure 63. Bayer Revenue Growth Rate in Heart Failure Treatment Business (2019-2024)
    Figure 64. BMS Revenue Growth Rate in Heart Failure Treatment Business (2019-2024)
    Figure 65. Cardiorentis Revenue Growth Rate in Heart Failure Treatment Business (2019-2024)
    Figure 66. Cytokinetics Revenue Growth Rate in Heart Failure Treatment Business (2019-2024)
    Figure 67. Ono Pharmaceuticals Revenue Growth Rate in Heart Failure Treatment Business (2019-2024)
    Figure 68. Mylan Revenue Growth Rate in Heart Failure Treatment Business (2019-2024)
    Figure 69. NCPC Revenue Growth Rate in Heart Failure Treatment Business (2019-2024)
    Figure 70. Xinhua Group Revenue Growth Rate in Heart Failure Treatment Business (2019-2024)
    Figure 71. Xudong Haipu Pharmaceutical Revenue Growth Rate in Heart Failure Treatment Business (2019-2024)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Heart Failure Therapeutics Market Research Report 2024
Global Hypertension and Heart Failure Drugs Market Insights Forecast to 2030
Medicines for Congestive Heart Failure Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Heart Failure Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hypertension and Heart Failure Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ventricular Tachycardia Treatment Market Insights Forecast to 2030
Global Cardiomyopathy Medication Market Insights Forecast to 2030
Global Cardiac Arrhythmia Therapeutics Market Research Report 2025
Global Cardiac Autonomic Neuropathy Treatment Market Research Report 2024
Chronic Heart Failure CHF Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cardiac Cirrhosis Treatment Market Research Report 2024
Congestive Heart Failure Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Implantable Heart Failure Devices Market Research Report 2024
Global Heart Failure Devices Market Research Report 2024
Global Implantable Cardiac Resynchronization Therapy Equipment Market Research Report 2024
Global Heart Failure Mornitoring Software Market Research Report 2024
Global Digoxin API Market Insights Forecast to 2030
Global Dilated Cardiomyopathy Therapeutics Market Insights Forecast to 2030
Global Heart Failure Testing Market Research Report 2024
Global Dilated Cardiomyopathy Therapeutic Market Insights Forecast to 2030

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions